Login with your work email address to view charts. No credit card required.
| Art Unit: | 1636 — Chemistry: molecular biology and microbiology |
|---|---|
| Group: | 1630 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| Classes: |
435 — Chemistry: molecular biology and microbiology 514 — Drug, bio-affecting and body treating compositions 536 — Organic compounds -- part of the class 532-570 series 424 — Drug, bio-affecting and body treating compositions 800 — Multicellular living organisms and unmodified parts thereof and related processes 436 — Chemistry: analytical and immunological testing |
| Phone: | Available with subscription |
| Email: | Available with subscription |
| Title: | Pat Examnr (Biolgy) |
| Service: | 4 years |
| Grade: | GS-12 |
| 3-Year Grant rate: | 37% over 70 cases |
|---|---|
| Difficulty: | Very Hard |
| Difficulty Percentile: | 87th
|
With Examiner Rega, you have a 37% chance of getting an issued patent by 3 years after the first office action. Examiner Rega is a very hard examiner and in the 87th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Rega, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Rega's grant rate is lower than that of Art Unit 1636 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Rega | 1.8 |
| Art Unit 1636 | 1.9 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.